Paper · 42777063
References92
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 92
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37014931 | CHARMM-GUI Membrane Builder: Past, Current, and Future Developments and Applications. | J Chem Theory Comput | 2023 | https://conductscience.org/library/papers/37014931 | PubMed |
| 2 | 21982300 | Open Babel: An open chemical toolbox. | J Cheminform | 2011 | https://conductscience.org/library/papers/21982300 | PubMed |
| 3 | 16046613 | Analysis of allosterism in functional assays. | J Pharmacol Exp Ther | 2005 | https://conductscience.org/library/papers/16046613 | PubMed |
| 4 | 26962172 | Discovery and Characterization of a Novel Small-Molecule Agonist for Medium-Chain Free Fatty Acid Receptor G Protein-Coupled Receptor 84. | J Pharmacol Exp Ther | 2016 | https://conductscience.org/library/papers/26962172 | PubMed |
| 5 | 37277332 | Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84. | Nat Commun | 2023 | https://conductscience.org/library/papers/37277332 | PubMed |
| 6 | 16113085 | Allosteric modulation of the cannabinoid CB1 receptor. | Mol Pharmacol | 2005 | https://conductscience.org/library/papers/16113085 | PubMed |
| 7 | 35427647 | Selective phosphorylation of threonine residues defines GPR84-arrestin interactions of biased ligands. | J Biol Chem | 2022 | https://conductscience.org/library/papers/35427647 | PubMed |
| 8 | 32243800 | Impact of GPCR Structures on Drug Discovery. | Cell | 2020 | https://conductscience.org/library/papers/32243800 | PubMed |
| 9 | 25400877 | Building Water Models: A Different Approach. | J Phys Chem Lett | 2014 | https://conductscience.org/library/papers/25400877 | PubMed |
| 10 | 35538063 | The pocketome of G-protein-coupled receptors reveals previously untargeted allosteric sites. | Nat Commun | 2022 | https://conductscience.org/library/papers/35538063 | PubMed |
| 11 | 21500218 | MDAnalysis: a toolkit for the analysis of molecular dynamics simulations. | J Comput Chem | 2011 | https://conductscience.org/library/papers/21500218 | PubMed |
| 12 | 28800393 | POVME 3.0: Software for Mapping Binding Pocket Flexibility. | J Chem Theory Comput | 2017 | https://conductscience.org/library/papers/28800393 | PubMed |
| 13 | 34497417 | Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosis. | Nature | 2021 | https://conductscience.org/library/papers/34497417 | PubMed |
| 14 | 17629965 | Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology. | Trends Pharmacol Sci | 2007 | https://conductscience.org/library/papers/17629965 | PubMed |
| 15 | 25443960 | CHARMM-GUI PDB manipulator for advanced modeling and simulations of proteins containing nonstandard residues. | Adv Protein Chem Struct Biol | 2014 | https://conductscience.org/library/papers/25443960 | PubMed |
| 16 | 8744570 | VMD: visual molecular dynamics. | J Mol Graph | 1996 | https://conductscience.org/library/papers/8744570 | PubMed |
| 17 | 17849009 | Automated builder and database of protein/membrane complexes for molecular dynamics simulations. | PLoS One | 2007 | https://conductscience.org/library/papers/17849009 | PubMed |
| 18 | 15264254 | UCSF Chimera--a visualization system for exploratory research and analysis. | J Comput Chem | 2004 | https://conductscience.org/library/papers/15264254 | PubMed |
| 19 | 16264435 | New concepts in drug discovery: collateral efficacy and permissive antagonism. | Nat Rev Drug Discov | 2005 | https://conductscience.org/library/papers/16264435 | PubMed |
| 20 | 39217154 | Structural basis for CCR6 modulation by allosteric antagonists. | Nat Commun | 2024 | https://conductscience.org/library/papers/39217154 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/42777063/references